<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04791098</url>
  </required_header>
  <id_info>
    <org_study_id>RBHP 2019 LESENS</org_study_id>
    <secondary_id>2019-A02304-53</secondary_id>
    <nct_id>NCT04791098</nct_id>
  </id_info>
  <brief_title>Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital</brief_title>
  <acronym>PREVAGREF</acronym>
  <official_title>Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Solid-organ transplant patients are at increased risk of infectious diseases. Among this&#xD;
      population, infectious diseases may be life-threatening or lead to graft rejection. Their&#xD;
      prevention is an important challenge. Despite specific national recommendations, vaccination&#xD;
      is underutilized. That is why we propose a dedicated infectious diseases consultation during&#xD;
      pre-kidney transplantation assessment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to impove vaccine coverage before kidney transplantation.&#xD;
&#xD;
      Enrollment was based on the waiting list for a kidney transplant. Patients newly listed are&#xD;
      invited to participate by the transplant team (nephrology department) ; for those that are&#xD;
      already registered, a notification letter is sent to their home.&#xD;
&#xD;
      All patients included must :&#xD;
&#xD;
        -  complete a health questionnaire&#xD;
&#xD;
        -  take a blood test at day 0 : viral, bacterial and parasitic serologies, QuantiFERON-TB&#xD;
&#xD;
        -  take a chest X-ray and dental panoramic Patients randomized in interventional group will&#xD;
           be seen in specific infectious diseases consultation at Clermont Ferrand Hospital. A&#xD;
           letter of recommendations is sent to nephrologist for patients randomized in group&#xD;
           control.&#xD;
&#xD;
      The primary study endpoint (immunization coverage) is evaluated at 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2020</start_date>
  <completion_date type="Anticipated">April 2026</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaccination coverage</measure>
    <time_frame>Month 6</time_frame>
    <description>The percentage of fully immunized patients according to the Recommendations of High Council for public Health</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infectious complications</measure>
    <time_frame>within the 6 months of the transplantation</time_frame>
    <description>Infectious diseases which require special management (hospitalization, anti-infective treatments)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Month 6</time_frame>
    <description>Mortality after kidney transplantation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Kidney Transplantation</condition>
  <arm_group>
    <arm_group_label>Stronger pre-transplant check-up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>routine patient management + specific infectious diseases consultation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard pre-transplant check-up</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>routine patient management + letter sent to nephrologist</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Specific infectious diseases consultation</intervention_name>
    <description>Specific infectious diseases consultation at Clermont Ferrand Hospital with a specialist doctor :&#xD;
Update vaccinations&#xD;
Advice to travelers&#xD;
Diagnostic and treatment of latent tuberculosis infection</description>
    <arm_group_label>Stronger pre-transplant check-up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient over 18&#xD;
&#xD;
          -  On the waiting list for kidney transplantation at Clermont-Ferrand&#xD;
&#xD;
          -  Free and informed consent&#xD;
&#xD;
          -  Affiliation to a social security system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient under 18&#xD;
&#xD;
          -  Protected adults (individuals under guardianship by court order&#xD;
&#xD;
          -  Pregnant and nursing women&#xD;
&#xD;
          -  Prior graft (solid organs or hematopoietic stem cells)&#xD;
&#xD;
          -  Absence of consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Lesens</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise LACLAUTRE</last_name>
    <phone>+334 73 754 963</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise LACLAUTRE</last_name>
      <phone>+33473754963</phone>
      <email>promo_interne_drci@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier Lesens</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Immunization Coverage</keyword>
  <keyword>Transplant Recipient</keyword>
  <keyword>Transplantation, Kidney</keyword>
  <keyword>Infectious Disease Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

